Podcast #287 · 30 Jan 2026
Urothelial Carcinoma: Understanding ctDNA & Precision Medicine
- Radiation Oncology
- Urothelial Carcinoma
- Medical Oncology
- Radical Cystectomy
- Urology
- Immunotherapy
- Biomarkers
- Antibody-Drug Conjugates (ADCs)
- Circulating Tumor DNA (ctDNA)
- Neoadjuvant Chemotherapy
- Muscle Invasive Bladder Cancer (MIBC)
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative strategies in bladder cancer continue to evolve, emerging tools like circulating tumor DNA (ctDNA) are playing a bigger role in how clinicians assess recurrence risk and tailor treatment. In this episode of BackTable Tumor Board, host Alan Tan, medical oncologist at Vanderbilt-Ingram Cancer Center, is joined by bladder cancer experts Dr. Amanda Nizam and Dr. Brad McGregor to discuss recent advances in the diagnosis and treatment of urothelial carcinoma.